Kaimen Rigor reviewed

Rigor-Reviewed Manuscript

Provision of knee bracing for knee osteoarthritis (PROP OA): multicentre, parallel group, superiority, statistician blinded, randomised controlled trial.

Name: Kaimen Rigor review — Provision of knee bracing for knee osteoarthritis (PROP OA): multicentre, parallel group, superiority, statistician blinded, randomised controlled trial.
Item: Provision of knee bracing for knee osteoarthritis (PROP OA): multicentre, parallel group, superiority, statistician blinded, randomised controlled trial.
Rating: 92
Author: Alpha1

Holden MA, Nicholls E, Abdali Z, Birrell F, Borrelli B, Callaghan M, Dziedzic K, Felson D, Foster NE, Halliday N, Ingram C, Jinks C, Jowett S, Peat G, PROP OA trial team

Paper source

Read full text (PMC)

Embed this Rigor badge

Kaimen Rigor review — 4.25★ (Strong), 0 critical, 1 high issue for “Provision of knee bracing for knee osteoarthritis (PROP OA): multicentre, parallel group, superiority, statistician blinded, randomised controlled trial.”

Links back to this Kaimen Rigor review.

Alpha1 Editorial

This rigor review was examined and confirmed by Alpha1 Editorial · August 10, 2026

Read alongside

Provision of knee bracing for knee osteoarthritis (PROP OA): multicentre, parallel group, superiority, statistician blinded, randomised controlled trial.

Holden MA, Nicholls E, Abdali Z, Birrell F, Borrelli B, Callaghan M, Dziedzic K, Felson D, Foster NE, Halliday N, Ingram C, Jinks C, Jowett S, Peat G, PROP OA trial team

Read full text (PMC)

DOI

10.1136/bmj-2025-086005

Share this Kaimen Rigor review

Post on X Share on LinkedIn Share via Email

Embed this Rigor badge

<a href="https://alpha1science.com/verify/bf9ad03a-03d5-4f97-b432-db4d264fcb5b" target="_blank" rel="noopener">
  <img src="https://alpha1science.com/verify/bf9ad03a-03d5-4f97-b432-db4d264fcb5b/badge" alt="Kaimen Rigor review — 4.25★ (Strong), 0 critical, 1 high issue for “Provision of knee bracing for knee osteoarthritis (PROP OA): multicentre, parallel group, superiority, statistician blinded, randomised controlled trial.”" width="440" height="104" style="max-width:100%;height:auto" />
</a>

Every embed links back to this Kaimen Rigor review.

Record fingerprint

2e74a56f7ba703b50d775926fd205933ae049f988fa786922ff83180262cc69e

Verify via API

Issued Aug 10, 2026Engine 7.29.0

Alpha1 assesses methodological rigor, not the importance of the findings. See how we calibrate →

Alpha¹ by Kaimen

Fetching the latest research

Kaimen Rigor reviewed

Rigor-Reviewed Manuscript

Provision of knee bracing for knee osteoarthritis (PROP OA): multicentre, parallel group, superiority, statistician blinded, randomised controlled trial.

Holden MA, Nicholls E, Abdali Z, Birrell F, Borrelli B, Callaghan M, Dziedzic K, Felson D, Foster NE, Halliday N, Ingram C, Jinks C, Jowett S, Peat G, PROP OA trial team

Paper source

Provision of knee bracing for knee osteoarthritis (PROP OA): multicentre, parallel group, superiority, statistician blinded, randomised controlled trial.

Read full text (PMC)

Embed this Rigor badge

Links back to this Kaimen Rigor review.

Alpha1 Editorial

This rigor review was examined and confirmed by Alpha1 Editorial · August 10, 2026

Kaimen Rigor review

Kaimen Rigor reviewed

4.25 / 5

Strong — minor issues to address

Interventional Study

Critical

High-priority

How this rating was calculated▸

Started at 5★ — deductions

ClaimsTreatment effect not shown to be clinically meaningful−0.5★
ReportingEthical approvals partially met−0.25★

Model-reported confidence: highReviewer agreement: moderateEngine: 7.29.0Source: full text

Biggest issues

01Treatment effect not shown to be clinically meaningful
highOverreachreviewer-assessedFull detail
The primary effect on KOOS-5 at 6 months was an adjusted mean difference of 3.39 points (effect size 0.24), which the manuscript explicitly states did not reach the predefined minimal clinically important difference of 8 points. The effect is thus below the established MCID and not anchored to clinical meaningfulness.
“The treatment effect for the primary outcome did not reach the predefined minimum clinically important difference of eight points on KOOS-5, used to inform our sample size calculation.”
Find in source

Findings by category

01ArithmeticNone found 202OverreachOverstated conclusions 03AuthenticityNone found 104DisclosureReporting gaps 05AvailabilityNone found 06Copyedit4 minor suggestions

This Kaimen Rigor review uses Kaimen Rigor reviewers trained on a curated corpus of high-fidelity and retracted papers, with expert supervision and curation. It can still make mistakes; verify each finding against the source before relying on it.

PROP OA is a methodologically strong, transparently reported multicentre superiority RCT of adding knee bracing plus an adherence intervention to advice, information and exercise instruction for knee osteoarthritis. Computerised stratified randomisation, statistician blinding, pre-specified power and missing-data estimand, open data/code, registration and proportional conclusions are all in place. The only substantive gap is the absence of an explicit named regulatory-framework statement (ethics warn), alongside a missing CONSORT checklist reference and minor copyedit artifacts.

Full-text audit synthesizing three independent reviewer runs; the reviewers converged on six of eight dimensions at pass and diverged narrowly on ethical approvals (1 pass vs 2 warn) and data code availability (2 pass vs 1 warn), resolved here as warn and pass respectively. Statistics verification recomputed 2/2 reported test/CI values consistently (coverage limited to tests with a test statistic + df or an effect + CI; threshold-only p-values and resampling-based values were not machine-verifiable), the citation check found 0/34 retracted or unresolvable references, and the reproducibility check confirmed 2/2 links live. No integrity-lens concern was raised.

Numerical inconsistencies

None found

Values that contradict each other or are impossible for the stated sample: recomputed p-values and test statistics, GRIM/GRIMMER checks on summary numbers, percentages against their own counts, totals against their parts, and estimates against their own confidence intervals.

Checked — nothing surfaced.

Recomputed 2 tests: 2 consistent, 0 inconsistent; 2 via agent-written checks.

Overstated conclusions

2 findings · worst high

Conclusions that reach past what the paper's own results support — including a significance claim that no longer holds when the statistic is recomputed, and efficacy resting on an unvalidated surrogate endpoint.

Treatment effect not shown to be clinically meaningfulAssessed
Conclusions only partially backed by the presented evidenceAssessed

12 major claims checked against the paper's own evidence: all adequately supported.

Premise concern: effect size not shown to be clinically meaningful.

Data authenticity concerns

None found

An adversarial read for patterns associated with data that may not be genuine: results that look too clean, implausibly large effects, duplicated data or images, and methods that do not match the results reported.

Checked — nothing surfaced.

Reporting gaps

1 finding · worst medium

Required detail the manuscript never states — study design, biological variables, ethics approval and consent, key resources, statistical reporting, data and code availability, and overall transparency.

Ethics/consent reporting incompleteAssessed

Eight Dimensions7 pass · 1 warn

Prior research is cited, including conflicting international guidelines, sparse high-quality RCTs, and inconclusive systematic reviews. The rationale for a large, independent trial with outcomes beyond 6 months follows logically, and the design directly targets previous limitations: compartment-specific bracing, adherence promotion and measurement, large sample, and longer follow-up.

Sub-criteria

prior work citedADEQUATE

premise rationaleADEQUATE

limitations addressedADEQUATE

Per reviewer (3) — the votes behind the verdict

PASSReviewer 1· 95% conf

The introduction establishes clinical uncertainty and conflicting guidance on knee bracing, and the trial is explicitly positioned to address the limitations of prior RCTs.

Evidence

“Internationally, clinical guidelines offer conflicting recommendations on the use of knee bracing for knee osteoarthritis, and evidence from high quality randomised controlled trials is sparse.”

IntroductionFind in source

“Previous systematic reviews have been inconclusive because of limitations in existing trials, such as risk of bias, small sample sizes, short follow-up, and lack of targeting of adherence”

What is already known on this topicFind in source

“PROP OA addressed these challenges by tailoring the type of brace to participant presentation and incorporating strategies to promote and measure adherence to the use of the brace.”

DiscussionFind in source

PASSReviewer 2· 90% conf

The premise is well grounded: the introduction documents conflicting guidelines and sparse high-quality trial evidence, and the rationale and design choices respond directly to prior trials' limitations.

Evidence

“Internationally, clinical guidelines offer conflicting recommendations on the use of knee bracing for knee osteoarthritis, and evidence from high quality randomised controlled trials is sparse.”

IntroductionFind in source

paraphrase[Introduction]

“The PROP OA trial was designed to answer the need for a large, independent, high quality randomised controlled trial with outcomes for >6 months.”

“PROP OA addressed these challenges by tailoring the type of brace to participant presentation and incorporating strategies to promote and measure adherence to the use of the brace.”

DiscussionFind in source

PASSReviewer 3· 95% conf

The paper clearly establishes the scientific foundation by citing prior conflicting guidelines and sparse evidence, providing a logical rationale for the trial, and explicitly addressing limitations of prior research.

Evidence

“Internationally, clinical guidelines offer conflicting recommendations on the use of knee bracing for knee osteoarthritis, and evidence from high quality randomised controlled trials is sparse.”

Introduction ¶2Find in source

paraphrase[Introduction, paragraph 3]

“The PROP OA trial was designed to answer the need for a large, independent, high quality randomised controlled trial with outcomes for >6 months.”

“Before PROP OA, randomised controlled trials of knee bracing for knee osteoarthritis were hampered by targeting only one knee compartment for all participants, small sample sizes, risk of bias, lack of follow-up beyond three months, and heterogeneity.”

DiscussionFind in source

Randomisation used a centralised web-based service with stratified random permuted blocks (sizes 2, 4, 6); participants are the unit of randomisation. The statistician was masked, with explicit rationale for inability to mask participants or physiotherapists. The sample size calculation used an effect size of 0.35, 90% power, 5% significance, and allowed for 20% loss to follow-up. Missing data were handled through a treatment-policy estimand, multiple imputation, and sensitivity analyses, which meets the human-RCT mapping of the outlier/analysis-population criterion.

Sub-criteria

controlsN/A

power analysisADEQUATE

blinding levelsADEQUATE

outlier handlingADEQUATE

randomization unitADEQUATE

inclusion exclusionADEQUATE

randomization methodADEQUATE

replicate distinctionN/A

independent replicationN/A

Per reviewer (3) — the votes behind the verdict

PASSReviewer 1· 95% conf

Well-designed trial with pre-specified sample size, computerised stratified block randomisation, statistician blinding, detailed inclusion/exclusion criteria, and a clear handling of missing data.

Evidence

“We used a computerised web based randomisation service and random number generator, stratified by clinic site, predominant compartmental distribution of knee osteoarthritis (based on a combination of clinical assessment and radiographic presentation), and the presence of instability (buckling), with a 1:1 allocation with random permuted blocks of sizes 2, 4, and 6.”

Provision of knee bracing for knee osteoarthritis (PROP OA): multicentre, parallel group, superiority, statistician blinded, randomised controlled trial.

Provision of knee bracing for knee osteoarthritis (PROP OA): multicentre, parallel group, superiority, statistician blinded, randomised controlled trial.

Numerical inconsistencies

Overstated conclusions

Data authenticity concerns

Reporting gaps

Broken references and links

Copyediting

Numerical inconsistencies

Overstated conclusions

Data authenticity concerns

Reporting gaps

Broken references and links

Copyediting